CCL13 anticorps

N° du produit ABIN636542

Détail du produit anti-CCL13 anticorps

Antigène: CCL13 (Chemokine (C-C Motif) Ligand 13 (CCL13))

Reactivité: Humain

Hôte: Lapin

Clonalité: Polyclonal

Conjugué: Cet anticorp CCL13 est non-conjugé

Application: Western Blotting (WB), ELISA, Blocking Antibody (Inhibition)

Purification: Purified

Immunogène: MCP4 antibody was raised in rabbit using highly pure recombinant hMCP-4 as the immunogen.

Information d'application

Indications d'application: ELISA: 0.5-2 µg/mL, Inhibition: 1-1.5 µg/mL, WB: 0.1-0.2 µg/mL
Optimal conditions should be determined by the investigator.

Restrictions: For Research Use only

Stockage

Format: Lyophilized

Concentration: Lot specific

Buffer: Lyophilized from PBS, pH 7.2.

Conseil sur la manipulation: Avoid repeated freeze/thaw cycles.
Dilute only prior to immediate use.

Stock: 4 °C/-20 °C

Stockage commentaire: Store at -20 °C until reconstitution. Following reconstitution product may be stored at 4 °C in the short term. For long term storage aliquot and freeze at -20 °C.

Détails sur CCL13

Antigène: CCL13 (Chemokine (C-C Motif) Ligand 13 (CCL13))

Autre désignation: MCP4 (CCL13 Produits)

Synonymes: anticorps CKb10, anticorps MCP-4, anticorps NCC-1, anticorps NCC1, anticorps SCYA13, anticorps SCYL1, anticorps C-C motif chemokine ligand 13, anticorps chemokine (C-C motif) ligand 13, anticorps CCL13

Sujet: The MCP proteins belong to the CC chemokine family, and signal through CCR2 and, with the exception of MCP-1, other CCR receptors. The MCP proteins chemoattract and activate monocytes, activated T cells, basophils, NK cells, and immature dendritic cells. The MCP family cross reacts across species. MCP4 is also known as CCL13 and induces chemotaxis in monocytes, eosinophils, T lymphocytes, and basophils by binding cell surface G-protein linked chemokine receptors such as CCR2, CCR3 and CCR5.

Poids moléculaire: 8.6 kDa (predicted detection band MW)

Pathways: Regulation of Systemic Arterial Blood Pressure by Hormones, Phosphorylation & l'infection par le SRAS-CoV-2